ShockWave Medical, Inc. (SWAV) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Devices 산업에서 운영. 본사 소재지는 Santa Clara, CA, 미국. 현재 CEO는 Douglas E. Godshall.
SWAV 을(를) 보유 IPO 날짜 2019-03-07, 1,468 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $12.57B.
ShockWave Medical, Inc. is a medical device company that develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases globally. The company's product portfolio includes M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. ShockWave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists through a network of sales representatives, managers, and distributors. Founded in 2009 and headquartered in Santa Clara, California, the company addresses critical treatment needs across multiple vascular intervention markets.
